Antisera generated against each of seven synthetic peptides corresponding to constant and variable sequences of the pilin from gonococcal strain MS11 were assayed for their ability to crossreact with intact pili from both homologous and heterologous strains. The peptides elicited roughly equal antipeptide responses but varied substantially in their ability to elicit antisera that crossreacted with intact pili. Of the antisera to peptides corresponding to regions of conserved sequence, antisera directed against residues 69-84 were the most efficient in binding pili from all strains tested in both solid-phase assays and immunoblots. Anti-69-84 also efficiently precipitated a tryptic fragment of pilin known to bind human endocervical cells. Sera against the two peptides (121-134 and 135-151) previously shown to contain strain-specific epitopes crossreacted with MS11 pili equally well, but differed in their ability to bind pili from heterologous strains. Anti-121-134 was strain-specific whereas anti-135-151 bound all pilin tested. Each of the sera was examined for its ability to inhibit bacterial adhesion to a human endometrial carcinoma cell line. Sera generated against residues 41-50 and 69-84 successfully inhibited a heterologous gonococcal strain from binding. These peptides could be important components of an effective vaccine for the prevention of gonorrhea.
The antigenic variation of the surface molecules of pathogenic organisms is an important obstacle to the development of efficacious vaccines for a variety of diseases (1) (2) (3) (4) (5) (6) . In only a few systems are the molecular details of the sequence variation of the membrane proteins and the genetic mechanism for their variation partially understood (7, 8) .
Efforts to develop a successful vaccine against gonorrhea have concentrated on blocking the organism's binding to eukaryotic cell surfaces. Gonococcal adhesion to mucus membranes is mediated in part by pili, filamentous polymers that extend out from the bacterial surface (9) . These organelles are composed of a single repeating protein subunit, pilin. Pili prepared from different gonococcal strains are antigenically heterogeneous and attempts to use them as components of a vaccine have resulted only in protection against the homologous strain (10) . In an earlier investigation, we identified the linear strain-specific and common epitopes of gonococcal pilin (11) . By using synthetic peptides corresponding to different regions of the protein, we showed that antisera against pili from strain MS11 are predominantly strain specific and directed at two epitopes within a disulfide loop near the carboxyl terminus of the pilin molecule. We also determined that the sequence of this region varies greatly between different strains of gonococci. In contrast, the conserved, receptor-binding portion of the sequence (residues 31-92) contained only a weakly immunogenic epitope, common to all pili from the strains examined, between residues 48 and 60. However, when the central cyanogen bromide-generated fragment (CNBr II, residues 8-92) was used as an immunogen, a much stronger crossreactive response was generated which was directed at a region between residues 69 and 84. This was the first indication that peptides from pilin can elicit a different population of antibodies than that produced when the intact protein is used as an immunogen.
In this study we have used as immunogens the same peptides previously used as antigens to map the antigenic structure of gonococcal pilin (11) . Antisera generated against the synthetic peptides were examined for their ability to crossreact with intact pili from homologous and heterologous strains by solid-phase binding assays and immunoblots. The sera also were used to immunoprecipitate an iodinated tryptic fragment of pilin previously shown to bind human endocervical cells (12) . Finally, sera against residues 41-50 and 69-84 separately were shown to inhibit intact bacteria from binding human endometrial carcinoma cells.
MATERIALS AND METHODS
Gonococcal Strains and Growth Medium. The isolation and maintenance of gonococcal strains MS11 and R10 have been described (12) . Strain 1896 was isolated in Seattle from a patient with a disseminated gonococcal infection, whereas R16, F62, and 2686 were provided by the Cornell University School of Medicine, New York and D. S. Kellogg, Jr. (Center for Disease Control, Atlanta) from patients with uncomplicated gonorrhea. The four colonial variants [piliated/opaque (op) or transparent (t) and nonpiliated/opaque or transparent] of each strain were independently propagated on solid typing medium by selective daily passage of single colonies (13) .
Purification of Pili. Pili were purified from MS11 (t) and R10 (t) strains of N. gonorrhoeae as described (12) .
Selection and Synthesis of Peptides. The peptides corresponding to regions of MS11 pilin in this study were the same as those used to determine the antigenic structure of the molecule (11) . Peptides were synthesized by solid-phase techniques (14) with a Beckman model 990B peptide synthesizer using commercially available amino acid polystyrene resins and tert-butoxycarbonyl-protected amino acids (Peninsula Laboratories, Belmont, CA).
Conjugation of the Peptides to Carrier Proteins. The peptides were conjugated to bovine serum albumin (BSA) with succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Pierce) as described (11) . For immunization, they were conjugated to thyroglobulin with m-maleimidobenzoyl N-hydroxysuccinimide ester (Pierce). The conjugates used in this study each contained 15-25 peptides per molecule of BSA and 25-35 peptides per 100 kDa of thyroglobulin.
Abbreviation: BSA, bovine serum albumin.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Immunoblots. Intact colonies of gonococci grown on agar were removed with filter paper and lysed with NaDodSO4/ PAGE sample buffer. The lysates were loaded directly onto a 12% polyacrylamide/NaDodSO4 gel and electrophoresed. The resolved bacterial proteins were electrophoretically transferred onto nitrocellulose (BA83, Schleicher and Schuell) and the membrane was treated with 95% P,/NaCl (0.15 M NaCl/0.01 M sodium phosphate, pH 7.4)/5% skim milk at 37°C for several hours to saturate the matrix. The nitrocellulose was then incubated with appropriate dilutions of antipeptide sera, washed, exposed to 100,000 cpm of 125I1 labeled protein A, washed, dried, and autoradiographed.
Immunoprecipitations. TC-2 (residues 31-111), a receptorbinding tryptic peptide of pili, was generated, purified, and iodinated as described (12 
Corresponding sequence locations in MS11 pilin are given beneath the sequence of each peptide. Underlined residues do not exist in the primary structure of MS11 pilin; these glycine and cysteine residues were added as spacers and for attachment to carrier molecules, respectively. The single-letter amino acid code is used (15).
coverslips. The mixture was incubated with gentle rocking for 1 hr at 37°C, after which the coverslips were washed with P1/NaCl, fixed with methanol, and treated with Giemsa stain. The number of bacteria bound per cell was determined visually.
RESULTS
The MS11 synthetic peptide analogues used in this study (Table 1) correspond to regions both of conserved sequence (residues [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , 41-50, 48-60, and 69-84) and of variable sequence (residues 107-121, 121-134, and 135-151) between pilin from various gonococcal strains (12) . Fourteen rabbits were immunized with the seven peptides conjugated to thyroglobulin (two rabbits per conjugate). The resultant antisera were screened for their ability to bind the homologous peptide conjugated to BSA as well as for their ability to crossreact with intact MS11 and R10 pili (Fig. 1) . Similar results were obtained with the sera from both rabbits immunized with each peptide. Though not identical in their immunogenicity, all of the peptides elicit good antipeptide responses. However, they substantially differed in their ability to generate antibodies that crossreacted with the intact pilus proteins. Not surprisingly, the sera engendered by immunizing 
Proc. NatL Acad Sci. USA 82 (1985) Proc. NatL Acad. Sci. USA 82 (1985) with peptides from regions of sequence identity between MS11 and R10 pili crossreacted equally well with the two proteins ( Fig. 1 A-D (Fig. 2) , as did sera from rabbits immunized with 135-151 (Fig. 3) . In contrast, antibodies against 121-134 bound MS11 but not R10 pilin (Fig. 4) ; these sera crossreact only with heterologous pilin from strain F62 (data not shown).
To determine whether the sera against the peptides corresponding to the region of conserved sequence crossreact well enough with pili to be used as reagents to examine the biological functions of the protein, we examined their ability to immunoprecipitate TC-2 (residues 31-111). This peptide is prepared by tryptic digestion of citraconylated pilin and was shown previously to encompass a receptor-binding domain of gonococcal pili (12) . Antisera to residues 21-35, 41-50, 48-60, and 69-84 all immunoprecipitate this fragment (Fig.   5 ). Sera directed against 69-84 precipitate TC-2 much more effectively than the other antisera, even at dilutions of 1:50,000.
Antisera to each peptide were screened for their ability to block the binding of viable gonococci derived from piliated, transparent colonial variants to human endometrial carcinoma cells grown as monolayers on cover slips. Endometrial cells were used because (i) gonococcal endometritis is a well described phenomenon (16); (ii) they more closely resemble the epithelial cell in natural infection than do erythrocytes, which had been used in a previous study (17) ; and (iii) they are more readily bound by piliated gonococci than are either HeLa or buccal cells. Strain F62 was employed in these assays because (a) of the heterologous strains examined, it displayed the greatest capacity to bind the ENCA-4 endometrial cells and consequently provided the most stringent test of the antisera's capacity to block attachment; (b) the antisera to both the conserved sequence of the molecule and the two peptides composing the disulfide loop crossreacted with F62 pilin on immunoblots, therefore allowing comparison of the effectiveness of antibodies against the conserved sequences with that of antibodies against the variable domain to inhibit binding; and (c) this strain has been shown to cause urethritis in male volunteers (18) and thus has retained its pathogenicity after in vitro passage. Only antisera to peptides 41-50 and 69-84 efficiently prevented bacterial attachment ( 
DISCUSSION
A pathogen's ability to evade the host immune response by antigenic variation provides an intriguing system for study of the molecular details of the antigenicity and immunogenicity of proteins. When rabbits are immunized with purified gonococcal pili, the majority of antibodies are directed at two strain-specific epitopes within a disulfide loop between residues 121 and 151 (11) . Consequently, pili prepared from a single strain probably cannot be used as a broadly protective gonorrhea vaccine.
Experiments described in this paper provide evidence that synthetic peptides corresponding to weakly immunogenic regions of the protein can elicit antibodies that not only crossreact with the intact protein but also inhibit heterologous gonococcal strains from binding eukaryotic cells.
The seven peptides used as immunogens all evoked relatively equal antipeptide responses. The regions containing the highly immunogenic, strain-specific epitopes of the intact protein (121-134 greater antipeptide response than the other five peptides. However, antisera elicited by each of the seven peptide analogues of gonococcal pilin substantially differ in their ability to crossreact with the intact protein when assayed either by solid-phase binding, immunoblotting, or immunoprecipitation. The variation in the peptides' ability to generate a crossreactive response is best explained by the number and type of B-cell clones the peptides stimulate. When a synthetic peptide is used as an immunogen, the possible conformations that it can adopt will determine which clones in the Bcell repertoire are stimulated to produce antibodies. Only if the peptide adopts a secondary structure identical to that it assumes in the intact protein will it elicit antibodies that crossreact with that protein. We believe that the peptides that generate the highest anti-pili response (69-84, 121-134, and 135-151) have the highest probability of existing in the identical conformation they assume in pilin or have the lowest energy requirements for being induced to adopt the correct conformation by a complementary antibody combining site.
The regions of pilin that were synthesized were chosen based on their likelihood to adopt structures similar to their predicted conformation in the intact protein. Each peptide has a predicted reverse turn located distal to its site of linkage to the carrier protein. We believe that of the three known secondary structures-a-helix, /3-sheet, and reverse or (3- turns-reverse turns have the highest probability of occurring in a peptide <20 amino acids long. This conclusion is based on the supposition that the forces involved in sheet and helix formation are primarily found in the tertiary structure of the protein. Such interactions as inter-strand hydro- -4 gen bonding in sheets and hydrophobic bonds found in helixpacking and sheet-sheet interactions will be absent in a linear peptide. The structural forces responsible for reverse turns are much simpler. Turns invariably are composed of hydrophilic residues prominantly exposed on the surface of globular proteins, often with the first and fourth amino acids associated with a hydrogen bond (19) . Usually they are flanked by hydrophobic residues whose association is thought to be the driving force for turn formation (20) . Consequently, relatively short linear peptides can contain all the residues involved in turn formation.
Based on the mechanism of adhesion of other gram-negative bacteria (21) (22) (23) , pilin is most likely a lectin that binds a carbohydrate moiety on the eukaryotic cell surface. A high percentage of the residues that hydrogen-bond the ligand in the binding sites of the few carbohydrate-binding proteins whose three-dimensional structures have been determined (4, (24) (25) (26) (27) are present in turns. We felt that an antibody generated against a predicted turn in the conserved region of gonococcal pilin might block pili from binding eukaryotic membranes. These ideas appear to be correct because antibodies elicited by residues 41-50 and 69-84 from the constant portion of MS11 pilin inhibit strain F62 from attaching to endometrial cells in vitro. In contrast, attachment is not blocked by antibodies to two peptides distal to the receptorbinding segment: 121-134, which shares an epitope with F62 (data not shown), and 135-151, which elicits high-titer, crossreacting antibodies. Thus we propose that regions 41-50 and 69-84 are involved in receptor binding. The inhibition data also support our previous prediction that antibodies directed against the highly immunogenic regions within the disulfide loop would not block adhesion (11) .
Additional evidence that the immune response against peptides is distinct from that against the intact protein is the specificity of the antibodies generated against residues 135-151. In the intact protein this region elicits antibodies that are specific for MS11 pili. In contrast, the isolated peptide generates antibodies that bind not only MS11 pili but also pili from all other strains tested. Comparison of the sequences of pilins from different gonococcal strains indicates that residues 134-145 are variable but residues 146-151 are constant. That two separate epitopes can exist within a peptide this size is not surprising but rather that only the variable region is immunogenic when the intact protein is used as an immunogen, whereas both the variable and conserved regions are immunogenic when the peptide is used. We assume that the different responses are due to events involved in antigen presentation. Free antigen does not stimulate B-cells directly. Only when antigen is associated with immune-response gene products and the T-cell receptor is it capable of stimulating a humoral response (28) . These components of the immune system must associate with pilin and may prevent portions of its surface from being seen by the B-cell population.
The results presented in this report are consistent with earlier observations by Tramont et al. (29) that an intact pilus vaccine elicits receptor-blocking antibodies directed at a common epitope, since they could be absorbed with heterologous pili. In contrast, Virji and Heckels (30) have recently reported that strain-specific but not crossreacting monoclonal antibodies block attachment, although the location of their epitopes was not determined. Taken as a group, these studies and the data presented here suggest that both linear and nonlinear strain-specific and common epitopes probably exist and that representatives of each may elicit receptorblocking antibodies depending on their spatial proximity to the residues involved in ligand binding in the folded pilin molecule. These considerations notwithstanding, by eliciting sequence-specific, functionally defined antibodies, the synthetic peptides described in this report have enabled us to extend our previous structure-function analysis of pili. The peptides that elicit crossreacting, receptor-blocking antibodies are promising candidate immunogens for the prevention of gonorrhea.
